Alongi Pierpaolo, Laudicella Riccardo, Gentile Roberta, Scalisi Salvatore, Stefano Alessandro, Russo Giorgio, Grassedonio Emanuele, Albano Domenico, Pompei Giancarlo, Rossi Francesca, Raimondo Dario, Ganduscio Gloria, Midiri Massimo, Sinagra Emanuele
Nuclear Medicine Unit, Fondazione Istituto G. Giglio, Cefalù.
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina.
Nucl Med Commun. 2019 Oct;40(10):1060-1065. doi: 10.1097/MNM.0000000000001062.
To identify the clinical relevance of incidentally detected lesions (IDLs) in the gastrointestinal tract (GIT) with 18F-FDG PET/CT and to assess the potential benefit of using semiquantitative PET measures to discern malignant from benign lesions.
Forty-one patients who underwent F-FDG PET/CT scans during the oncologic follow-up, revealing abnormal incidental 18F-FDG accumulations in the GIT were included in this retrospective analysis. Incidental PET/CT findings were correlated with endoscopic and histological findings. Semiquantitative PET values (SUVmax, SUVmean, SULpeak, and TLG) were evaluated by using a new graph-based method. Two sample t-test analysis has been performed to evaluate the differences of PET parameters between precancerous or cancerous lesions and inflammatory disease.
Nine of the 41 patients had an IDL of the GIT on F-FDG PET/CT (detection rate 22%). Endoscopic examination and biopsy have confirmed the presence of precancerous or cancerous lesions as follow: colonic adenoma with high-grade dysplasia (N = 2), colonic adenoma with low-grade dysplasia (N =3), colonic metastatic lesion from primary breast cancer (N =1), gastric carcinoma (N=3). Precancerous or cancerous lesions showed a higher SUVmax, SUVmean, SULpeak, and TLG with a mean value of 10.6 (range, 5.3- 16.7), 6.2 (range, 2.1-10.6), 5.2 (2.7-11), and 66.6 (range, 7.4-164), than patients with inflammatory and endoscopically negative lesions. Two sample t-test analysis showed that SUVmean (P = 0.03), SULpeak (P = 0.05) were statistically different between the two subgroups.
The use of new semiquantitative PET parameters may increase the diagnostic yield of FDG PET in the case of abnormal incidental F-FDG accumulations.
利用18F-FDG PET/CT确定胃肠道(GIT)偶然发现病变(IDL)的临床相关性,并评估使用半定量PET测量来区分恶性和良性病变的潜在益处。
41例在肿瘤学随访期间接受F-FDG PET/CT扫描、显示GIT有异常偶然18F-FDG积聚的患者纳入本回顾性分析。偶然的PET/CT检查结果与内镜及组织学检查结果相关联。采用一种新的基于图形的方法评估半定量PET值(SUVmax、SUVmean、SULpeak和TLG)。进行两样本t检验分析以评估癌前或癌性病变与炎症性疾病之间PET参数的差异。
41例患者中有9例在F-FDG PET/CT上发现GIT的IDL(检出率22%)。内镜检查和活检证实存在以下癌前或癌性病变:高级别异型增生的结肠腺瘤(N = 2)、低级别异型增生的结肠腺瘤(N = 3)、原发性乳腺癌的结肠转移瘤(N = 1)、胃癌(N = 3)。癌前或癌性病变的SUVmax、SUVmean、SULpeak和TLG较高,平均值分别为10.6(范围5.3 - 16.7)、6.2(范围2.1 - 10.6)、5.2(2.7 - 11)和66.6(范围7.4 - 164),高于有炎症和内镜检查阴性的病变患者。两样本t检验分析显示,两个亚组之间SUVmean(P = 0.03)、SULpeak(P = 0.05)有统计学差异。
在偶然出现异常F-FDG积聚的情况下,使用新的半定量PET参数可能会提高FDG PET的诊断率。